from Reuters: Health News https://reut.rs/2PZY9Ll
Wednesday, May 15, 2019
Wednesday, May 15, 2019
MZ Digital Marketing Agency
HEALTH NEWS
No comments
Myovant Sciences Ltd said on Tuesday its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids.

from Reuters: Health News https://reut.rs/2PZY9Ll
from Reuters: Health News https://reut.rs/2PZY9Ll
Related Posts:
LATEST HEALTH NEWS(Reuters Health) - Being one of the youngest in a kindergarten class dramatically increases the odds that a child will be diagnosed and treated for attention deficit-hyperactivity disorder(ADHD), a large new U.S. study has co… Read More
LATEST HEALTH NEWSHe Jiankui had told a packed biomedical conference he was 'proud' to have successfully altered the DNA of twin girls born to an HIV-positive father from Health https://ift.tt/2KFLL08 … Read More
LATEST HEALTH NEWS(Reuters Health) - Despite improved survival rates for many cancers, a diagnosis can still be very distressing and may raise a patient's risk of suicide, researchers say. from Reuters: Health News https://ift.tt/2BDMlZD … Read More
LATEST HEALTH NEWSTobacco giant Altria Group Inc is in talks to take a significant minority stake in e-cigarette maker Juul Labs Inc, the Wall Street Journal reported on Wednesday, citing people familiar with the matter. from Reuters: Hea… Read More
LATEST HEALTH NEWS(Reuters Health) - - Many older drivers are taking multiple medications that may increase the risk of car crashes, a new U.S. study suggests. from Reuters: Health News https://ift.tt/2DNyRvQ … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment